We value keeping the Device Guide up to date.

Balt announced that the first patients in North America have been enrolled in its premarket approval clinical trial, PIONEER, ...

Endologix Holdings, LLC, announced that its new corporate brand is Rhevera Medical. According to its press release, Rhevera ( ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

Gore & Associates announced that the first patients were enrolled in the pivotal study of the company’s investigationa ...

Medtronic announced it has received Breakthrough Device designation from the FDA for its In.Pact below-the-knee (BTK) paclitaxel ...

Terumo Neuro announced that it has signed an agreement to acquire Arsenal Medical Inc., which is developing NeoCast, a ...

Inquis Medical, a developer of treatments for venous thromboembolic disease, announced the United States commercial launch of ...

TriSalus Life Sciences, Inc. announced it has received FDA 510(k) clearance for the company’s TriNav Advance, which exp ...

VS3 Medical, Inc., a developer of neurovascular implants, announced that the company’s VS3 system has been granted FDA ...

SRT provides a controlled method of expanding and remodeling the vessel that behaves consistently across the full range of ...

September 29, 2026—iVascular announced new phase 2 data from the OPAL study of Amber, the company’s liquid embolic. The ...